Population-based breast screening aims to reduce breast cancer mortality and morbidity through early detection and treatment [1]. Mammography, the most widely used screening method, is associated with an estimated 20 % reduction in breast cancer mortality within the screened population [2,3]. However, debate persists around the benefits and harms of breast cancer screening [2]. Effective screening relies on maximising benefits i.e., reduced mortality and morbidity whilst minimising harms i.e., a…